Generation of rapid in vitro diagnostic medical devices

We operate a gene-based division diagnosis device business and RNAi research-related product production and service business.

The main business, the in vitro diagnostic business, develops and sells nucleic acid extraction products that enable confirmation of the presence or absence of pathogens by extracting DNA or RNA from human-derived substances.

Nucleic acid extraction equipment shortens the time by more than 1/4 compared to the existing equipment to perform fast and efficient experiments. Currently, it is sold to general hospitals and inspection agencies.

2020/08/06 - [KOSPI] - LIG Nex1 leads defense industry by developing military drone motors

2020/07/29 - [KOSPI] - POSCO Chemical, the next generation anode material development and EV beneficiary

2020/07/28 - [KOSPI] - Hanwha Systems Leads Korean Defense with Situational Awareness Camera